APM
MRTX

Avidity Partners Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Avidity Partners Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,393,000
Closed -$115M – 101
2022
Q1 		$115M Buy
1,393,000
+586,600
+73% +$60M 2.54% 15
2021
Q4 		$118M Sell
806,400
-256,000
-24% -$39.7M 2.51% 10
2021
Q3 		$188M Buy
1,062,400
+309,400
+41% +$49.8M 4.79% 3
2021
Q2 		$122M Buy
753,000
+277,300
+58% +$44.5M 3.29% 6
2021
Q1 		$81.5M Buy
475,700
+95,700
+25% +$18.9M 2.27% 11
2020
Q4 		$83.5M Buy
380,000
+105,000
+38% +$22.7M 2.81% 10
2020
Q3 		$45.7M Buy
+275,000
New +$37.6M 2.46% 17
2020
Q2 		– Sell
-295,000
Closed -$22.7M – 81
2020
Q1 		$22.7M Buy
295,000
+231,000
+361% +$20.7M 3.25% 8
2019
Q4 		$8.25M Buy
+64,000
New +$6.17M 5.2% 5

Other funds holding MRTX

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return